Get started
Author

Yoji Honda

Recent trend of clinical features in patients with hepatocellular carcinoma
2011 · Yuko Nagaoki, Hideyuki Hyogo, et al. · Hepatology Research · 93
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections
2013 · Keiichi Kosaka, Nobuhiko Hiraga, et al. · Biochemical and Biophysical Research Communications · 83
PDF
Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib
2012 · Tomokazu Kawaoka, Hiroshi Aikata, et al. · Oncology · 69
Utility of controlled attenuation parameter measurement for assessing liver steatosis in J apanese patients with chronic liver diseases
2013 · Keiichi Masaki, Shintaro Takaki, et al. · Hepatology Research · 66
PDF
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
2021 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 55
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Oncology · 47
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
2018 · Kenichiro Kodama, Tomokazu Kawaoka, et al. · Journal of Gastroenterology and Hepatology · 39
Dynamic computed tomography appearance of tumor response after stereotactic body radiation therapy for hepatocellular carcinoma: How should we evaluate treatment effects?
2012 · Tomoki Kimura, Shigeo Takahashi, et al. · Hepatology Research · 32
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
2020 · Yuwa Ando, Tomokazu Kawaoka, et al. · Oncology · 30
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
2016 · Masahiro Hatooka, Tomokazu Kawaoka, et al. · PubMed · 30
Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin
2014 · Eisuke Murakami, Michio Imamura, et al. · Antimicrobial Agents and Chemotherapy · 18
PDF
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients
2017 · Hiromi Kan, Michio Imamura, et al. · Journal of Medical Virology · 14
Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients
2016 · Kei Morio, Michio Imamura, et al. · Journal of Gastroenterology and Hepatology · 12
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
2022 · Kei Amioka, Tomokazu Kawaoka, et al. · Cancers · 10
PDF
Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma
2013 · Shigeo Takahashi, Tomoki Kimura, et al. · Hepatology Research · 8
Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
2022 · Kei Amioka, Tomokazu Kawaoka, et al. · Cancers · 7
PDF
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy
2021 · Kei Amioka, Tomokazu Kawaoka, et al. · Oncology · 6
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma
2021 · Kensuke Naruto, Tomokazu Kawaoka, et al. · Oncology · 5
Relationship between sudden natural death and abdominal fat evaluated on postmortem CT scans
2016 · Y. Kaichi, H. Sakane, et al. · Obesity Science & Practice · 5
PDF
Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report
2015 · T. Kawaoka, M. Imamura, et al. · Transplantation Proceedings · 4
The Characteristics of Non-Obese Non-Alcoholic Fatty Liver Disease: Effect of Genetic and Environmental Factors
2016 · Y. Honda, T. Kessoku, et al. · Journal of Hepatology · 2
Characteristics of Fecal Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients: Aconnection between Endotoxin and NAFLD
2016 · T. Kessoku, K. Imajo, et al. · Journal of Hepatology · 1
[A case of clonorchiasis complicated with the expansion of liver cyst].
2013 · Yoko Kominami, Hiroshi Aikata, et al. · PubMed · 1
A case of acute hepatitis C with hepatitis C virus (HCV) genotype 3a -discussion of IL28-B-
2013 · Tomoki Kobayashi, Yoshiiku Kawakami, et al. · Kanzo · 1
PDF
Supplementary Material for: Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
2020 · Ando, Y., Kawaoka, T., et al. · Figshare
Works count: 30
Citation count: 638
H-index: 12
I10-index: 14
Year
Topic
Type